Contribution of rare inherited and de novo variants in 2,871 congenital heart disease probandsSheng Chih Jin, Martina Brueckner, James Knight et al.|Nature Genetics|2017Cited by 930
De novo mutations in congenital heart disease with neurodevelopmental and other congenital anomaliesJason Homsy, Wendy K. Chung, Samir Zaidi et al.|Science|2015Cited by 891
Results of the FUEL TrialDavid Goldberg, Victor Zak, Bryan H. Goldstein et al.|Circulation|2019Cited by 157
Valsartan in early-stage hypertrophic cardiomyopathy: a randomized phase 2 trialCarolyn Y. Ho, Eugene Braunwald, Sharlene M. Day et al.|Nature Medicine|2021Cited by 132
Quality of Life and Exercise Capacity in Early Stage and Subclinical Hypertrophic Cardiomyopathy: A Secondary Analysis of the VANISH TrialCatherine G. Ireland, Carolyn Y. Ho, Danielle S. Burstein et al.|Circulation Heart Failure|2024Cited by 6